Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis and Renal Damage in Congenital Abnormalities of the Kidney and Urinary Tract
2013-000309-21Phase 3Completed
- Sponsor
- IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico
- Start
- Jun 2013
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of amoxicillin, clavulanic acid, nitrofurantoin, cefixime, sulfamethoxazole and 1 more in vesicoureteral reflux (VUR) and urinary tract infection (UTI), sponsored by IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico. Primary endpoint: First symptomatic urinary tract infection rate over 24 months. Started Jun 2013; status: completed.
02
Drugs
amoxicillinclavulanic acidnitrofurantoincefiximesulfamethoxazole
03
Conditions
vesicoureteral reflux (VUR)urinary tract infection (UTI)
Beyond the preview
Go deeper on 2013-000309-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000309-21.